Inhibition of SDF-1 receptors CXCR4 and CXCR7 attenuates acute pulmonary inflammation via the adenosine A2B-receptor on blood cells

Cell Death and Disease

Volumn 8, Issue 5, 2017, Pages

  Konrad, Franziska Magdalena ^a   Meichssner, Nadine ^a   Bury, Annette ^a   Ngamsri, Kristian Christos ^a   Reutershan, Jörg ^a,b  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b INSTITUTE OF PATHOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE A2B RECEPTOR; CHEMOKINE RECEPTOR CXCR; CHEMOKINE RECEPTOR CXCR4; CMKOR1 PROTEIN, MOUSE; CXCR4 PROTEIN, MOUSE; HETEROCYCLIC COMPOUND; PLERIXAFOR; STROMAL CELL DERIVED FACTOR 1;

ACUTE DISEASE; ANIMAL; ANTAGONISTS AND INHIBITORS; BLOOD CELL; C57BL MOUSE; CAPILLARY PERMEABILITY; CELL MOTION; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; HEMATOPOIESIS; HUMAN; LUNG; MALE; METABOLISM; NEUTROPHIL; PATHOLOGY; PNEUMONIA; SIGNAL TRANSDUCTION; TIME FACTOR;

ACUTE DISEASE; ANIMALS; BLOOD CELLS; CAPILLARY PERMEABILITY; CELL MOVEMENT; CHEMOKINE CXCL12; GENE EXPRESSION REGULATION; HEMATOPOIESIS; HETEROCYCLIC COMPOUNDS; HUMANS; LUNG; MALE; MICE, INBRED C57BL; NEUTROPHILS; PNEUMONIA; RECEPTOR, ADENOSINE A2B; RECEPTORS, CXCR; RECEPTORS, CXCR4; SIGNAL TRANSDUCTION; TIME FACTORS;

EID: 85014591337     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/CDDIS.2016.482     Document Type: Article

References (37)

1. Matthay MA, Ware LB, Zimmerman GA. The acute respiratory distress syndrome. J Clin Invest 2012; 122: 2731–2740.
2. Herridge MS, Cheung AM, Tansey CM, Matte-Martyn A, Diaz-Granados N, Al-Saidi F et al. One-year outcomes in survivors of the acute respiratory distress syndrome. N Engl J Med 2003; 348: 683–693.
3. Grommes J, Soehnlein O. Contribution of neutrophils to acute lung injury. Mol Med 2011; 17: 293–307.
4. Aiuti A, Webb IJ, Bleul C, Springer T, Gutierrez-Ramos JC. The chemokine SDF-1 is a chemoattractant for human CD34+ hematopoietic progenitor cells and provides a new mechanism to explain the mobilization of CD34+ progenitors to peripheral blood. J Exp Med 1997; 185: 111–120.
5. Richard CL, Tan EY, Blay J. Adenosine upregulates CXCR4 and enhances the proliferative and migratory responses of human carcinoma cells to CXCL12/SDF-1alpha. Int J Cancer 2006; 119: 2044–2053.
6. Konrad FM, Braun S, Ngamsri KC, Vollmer I, Reutershan J. Heme oxygenase-1 attenuates acute pulmonary inflammation by decreasing the release of segmented neutrophils from the bone marrow. Am J Physiol Lung Cell Mol Physiol 2014; 307: L707–L717.
7. Rath D, Chatterjee M, Borst O, Muller K, Stellos K, Mack AF et al. Expression of stromal cell-derived factor-1 receptors CXCR4 and CXCR7 on circulating platelets of patients with acute coronary syndrome and association with left ventricular functional recovery. Eur Heart J 2014; 35: 386–394.
8. Chen WC, Tzeng YS, Li H, Tien WS, Tsai YC. Lung defects in neonatal and adult stromal-derived factor-1 conditional knockout mice. Cell Tissue Res 2010; 342: 75–85.
9. Eckle T, Koeppen M, Eltzschig HK. Role of extracellular adenosine in acute lung injury. Physiology 2009; 24: 298–306.
10. Konrad FM, Witte E, Vollmer I, Stark S, Reutershan J. Adenosine receptor A2b on hematopoietic cells mediates LPS-induced migration of PMNs into the lung interstitium. Am J Physiol Lung Cell Mol Physiol 2012; 303: L425–L438.
11. Yang D, Koupenova M, McCrann DJ, Kopeikina KJ, Kagan HM, Schreiber BM et al. The A2b adenosine receptor protects against vascular injury. Proc Natl Acad Sci USA 2008; 105: 792–796.
12. Martin C, Burdon PC, Bridger G, Gutierrez-Ramos JC, Williams TJ, Rankin SM. Chemokines acting via CXCR2 and CXCR4 control the release of neutrophils from the bone marrow and their return following senescence. Immunity 2003; 19: 583–593.
13. Petty JM, Sueblinvong V, Lenox CC, Jones CC, Cosgrove GP, Cool CD et al. Pulmonary stromal-derived factor-1 expression and effect on neutrophil recruitment during acute lung injury. J Immunol 2007; 178: 8148–8157.
14. Gambaryan N, Perros F, Montani D, Cohen-Kaminsky S, Mazmanian M, Renaud JF et al. Targeting of c-kit+ haematopoietic progenitor cells prevents hypoxic pulmonary hypertension. Eur Respir J 2011; 37: 1392–1399.
15. Tchernychev B, Ren Y, Sachdev P, Janz JM, Haggis L, O'Shea A et al. Discovery of a CXCR4 agonist pepducin that mobilizes bone marrow hematopoietic cells. Proc Natl Acad Sci USA 2010; 107: 22255–22259.
16. Kubo H, Graham L, Doyle NA, Quinlan WM, Hogg JC, Doerschuk CM. Complement fragment-induced release of neutrophils from bone marrow and sequestration within pulmonary capillaries in rabbits. Blood 1998; 92: 283–290.
17. van Eeden SF, Kitagawa Y, Klut ME, Lawrence E, Hogg JC. Polymorphonuclear leukocytes released from the bone marrow preferentially sequester in lung microvessels. Microcirculation 1997; 4: 369–380.
18. van Eeden SF, Lawrence E, Sato Y, Kitagawa Y, Hogg JC. Neutrophils released from the bone marrow by granulocyte colony-stimulating factor sequester in lung microvessels but are slow to migrate. Eur Respir J 2000; 15: 1079–1086.
19. Schmal H, Shanley TP, Jones ML, Friedl HP, Ward PA. Role for macrophage inflammatory protein-2 in lipopolysaccharide-induced lung injury in rats. J Immunol 1996; 156: 1963–1972.
20. Schumacher C, Clark-Lewis I, Baggiolini M, Moser B. High-and low-affinity binding of GRO alpha and neutrophil-activating peptide 2 to interleukin 8 receptors on human neutrophils. Proc Natl Acad Sci USA 1992; 89: 10542–10546.
21. Hung SC, Pochampally RR, Hsu SC, Sanchez C, Chen SC, Spees J et al. Short-term exposure of multipotent stromal cells to low oxygen increases their expression of CX3CR1 and CXCR4 and their engraftment in vivo. PLoS One 2007; 2: e416.
22. Tsai CC, Yew TL, Yang DC, Huang WH, Hung SC. Benefits of hypoxic culture on bone marrow multipotent stromal cells. Am J Blood Res 2012; 2: 148–159.
23. Ceradini DJ, Kulkarni AR, Callaghan MJ, Tepper OM, Bastidas N, Kleinman ME et al. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med 2004; 10: 858–864.
24. Costello CM, McCullagh B, Howell K, Sands M, Belperio JA, Keane MP et al. A role for the CXCL12 receptor, CXCR7, in the pathogenesis of human pulmonary vascular disease. Eur Respir J 2012; 39: 1415–1424.
25. Eltzschig HK, Bratton DL, Colgan SP. Targeting hypoxia signalling for the treatment of ischaemic and inflammatory diseases. Nat Rev Drug Discov 2014; 13: 852–869.
26. Ferrari D, Gulinelli S, Salvestrini V, Lucchetti G, Zini R, Manfredini R et al. Purinergic stimulation of human mesenchymal stem cells potentiates their chemotactic response to CXCL12 and increases the homing capacity and production of proinflammatory cytokines. Exp Hematol 2011; 393: 360–374.
27. Asai J, Takenaka H, Katoh N, Kishimoto S. Dibutyryl cAMP influences endothelial progenitor cell recruitment during wound neovascularization. J Invest Dermatol 2006; 126: 1159–1167.
28. Eckle T, Grenz A, Laucher S, Eltzschig HK. A2B adenosine receptor signaling attenuates acute lung injury by enhancing alveolar fluid clearance in mice. J Clin Invest 2008; 118: 3301–3315.
29. Hoegl S, Brodsky KS, Blackburn MR, Karmouty-Quintana H, Zwissler B, Eltzschig HK. Alveolar epithelial A2B adenosine receptors in pulmonary protection during acute lung injury. J Immunol 2015; 195: 1815–1824.
30. Koscso B, Trepakov A, Csoka B, Nemeth ZH, Pacher P, Eltzschig HK et al. Stimulation of A2B adenosine receptors protects against trauma-hemorrhagic shock-induced lung injury. Purinergic Signal 2013; 9: 427–432.
31. Schingnitz U, Hartmann K, Macmanus CF, Eckle T, Zug S, Colgan SP et al. Signaling through the A2B adenosine receptor dampens endotoxin-induced acute lung injury. J Immunol 2010; 184: 5271–5279.
32. Kreth S, Kaufmann I, Ledderose C, Luchting B, Thiel M. Reduced ligand affinity leads to an impaired function of the adenosine A2A receptor of human granulocytes in sepsis. J Cell Mol Med 2009; 13: 985–994.
33. Dushianthan A, Grocott MP, Postle AD, Cusack R. Acute respiratory distress syndrome and acute lung injury. Postgrad Med J 2011; 87: 612–622.
34. Konrad FM, Knausberg U, Hone R, Ngamsri KC, Reutershan J. Tissue heme oxygenase-1 exerts anti-inflammatory effects on LPS-induced pulmonary inflammation. Mucosal Immunol 2015; 9: 98–111.
35. Reutershan J, Stockton R, Zarbock A, Sullivan GW, Chang D, Scott D et al. Blocking p21-activated kinase reduces lipopolysaccharide-induced acute lung injury by preventing polymorphonuclear leukocyte infiltration. Am J Respir Crit Care Med 2007; 175: 1027–1035.
36. Reutershan J, Basit A, Galkina EV, Ley K. Sequential recruitment of neutrophils into lung and bronchoalveolar lavage fluid in LPS-induced acute lung injury. Am J Physiol Lung Cell Mol Physiol 2005; 289: L807–L815.
37. Konrad FM, Neudeck G, Vollmer I, Ngamsri KC, Thiel M, Reutershan J. Protective effects of pentoxifylline in pulmonary inflammation are adenosine receptor A2A dependent. FASEB J 2013; 27: 3524–3535.